That’s how long it took from the time AstraZeneca CEO Pascal Soriot greeted Virginia Governor Glenn Youngkin in his London office to announcing a $4 billion manufacturing facility in the state ...

British-Swedish pharmaceutical company AstraZeneca announced a $50 billion investment in the U.S. this week, with the Trump administration claiming some credit due to its tariff policy and Presiden… ...

AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

AstraZeneca CEO Pascal Soriot discusses the company's $50 billion investment in the U.S. economy. 'The Naked Gun' Early Reactions Are Overwhelmingly One-Sided Bill Maher admits he was wrong about ...

AstraZeneca announces that it will invest $50 billion in the U.S. by 2030, including a multi-billion-dollar manufacturing site in Virginia.

AstraZeneca has become the latest pharma firm to announce a multi-billion investment in the U.S. The Anglo-Swedish biotech firm has committed to spend $50 billion by 2030.

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming deadline of ramped-up tariffs from ...